These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29887449)

  • 21. Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.
    Calleja JL; Delgado S; del Val A; Hervás A; Larraona JL; Terán Á; Cucala M; Mearin F;
    Int J Colorectal Dis; 2016 Mar; 31(3):543-51. PubMed ID: 26694926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron Deficiency Impairs Developing Hippocampal Neuron Gene Expression, Energy Metabolism, and Dendrite Complexity.
    Bastian TW; von Hohenberg WC; Mickelson DJ; Lanier LM; Georgieff MK
    Dev Neurosci; 2016; 38(4):264-276. PubMed ID: 27669335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
    Cunha GJL; Rocha BML; Menezes Falcão L
    Eur J Intern Med; 2018 Jun; 52():1-7. PubMed ID: 29680173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-specific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathy.
    Ke BX; Pepe S; Grubb DR; Komen JC; Laskowski A; Rodda FA; Hardman BM; Pitt JJ; Ryan MT; Lazarou M; Koleff J; Cheung MM; Smolich JJ; Thorburn DR
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6165-70. PubMed ID: 22474353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J;
    J Perinat Med; 2017 May; 45(4):443-453. PubMed ID: 27278921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional abnormalities in iron-depleted heart.
    Kobak KA; Radwańska M; Dzięgała M; Kasztura M; Josiak K; Banasiak W; Ponikowski P; Jankowska EA
    Heart Fail Rev; 2019 Mar; 24(2):269-277. PubMed ID: 30284070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations.
    Schatz U; Arneth B; Siegert G; Siegels D; Fischer S; Julius U; Bornstein SR
    Atheroscler Suppl; 2013 Jan; 14(1):115-22. PubMed ID: 23357152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells.
    Kuvibidila SR; Porretta C
    J Cell Biochem; 2002; 86(3):571-82. PubMed ID: 12210763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal Iron Deficiency-Induced Hypothyroxinemia Impairs Early Brain Development Regardless of Normal Iron Levels in the Neonatal Brain.
    Hu X; Wang R; Shan Z; Dong Y; Zheng H; Jesse FF; Rao E; Takahashi E; Li W; Teng W; Teng X
    Thyroid; 2016 Jul; 26(7):891-900. PubMed ID: 27231981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-galactose induces a mitochondrial complex I deficiency in mouse skeletal muscle: potential benefits of nutrient combination in ameliorating muscle impairment.
    Chang L; Liu X; Liu J; Li H; Yang Y; Liu J; Guo Z; Xiao K; Zhang C; Liu J; Zhao-Wilson X; Long J
    J Med Food; 2014 Mar; 17(3):357-64. PubMed ID: 24476218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of iron deficiency on the secretion of interleukin-10 by mitogen-activated and non-activated murine spleen cells.
    Kuvibidila S; Yu L; Ode D; Velez M; Gardner R; Warrier RP
    J Cell Biochem; 2003 Oct; 90(2):278-86. PubMed ID: 14505344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.
    Evstatiev R; Alexeeva O; Bokemeyer B; Chopey I; Felder M; Gudehus M; Iqbal T; Khalif I; Marteau P; Stein J; Gasche C;
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):269-77. PubMed ID: 23078888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.
    Naqash A; Ara R; Bader GN
    BMC Womens Health; 2018 Jan; 18(1):6. PubMed ID: 29304848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?
    Silverberg DS; Wexler D; Schwartz D
    Int J Mol Sci; 2015 Jun; 16(6):14056-74. PubMed ID: 26096008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Iron Diet Increases Susceptibility to Noise-Induced Hearing Loss in Young Rats.
    Yu F; Hao S; Yang B; Zhao Y; Yang J
    Nutrients; 2016 Jul; 8(8):. PubMed ID: 27483303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial.
    Santas E; Miñana G; Cardells I; Palau P; Llàcer P; Fácila L; Almenar L; López-Lereu MP; Monmeneu JV; Sanchis J; Maceira AM; Bayés-Genís A; Núñez J;
    ESC Heart Fail; 2020 Dec; 7(6):4222-4230. PubMed ID: 33040491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-22 regulates iron availability in vivo through the induction of hepcidin.
    Smith CL; Arvedson TL; Cooke KS; Dickmann LJ; Forte C; Li H; Merriam KL; Perry VK; Tran L; Rottman JB; Maxwell JR
    J Immunol; 2013 Aug; 191(4):1845-55. PubMed ID: 23836059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
    Onken JE; Bregman DB; Harrington RA; Morris D; Acs P; Akright B; Barish C; Bhaskar BS; Smith-Nguyen GN; Butcher A; Koch TA; Goodnough LT
    Transfusion; 2014 Feb; 54(2):306-15. PubMed ID: 23772856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose.
    Sobrado CW; Cançado RD; Sobrado LF; Frugis MO; Sobrado MF
    Arq Gastroenterol; 2015 Dec; 52(4):255-9. PubMed ID: 26840464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study.
    Cortes X; Borrás-Blasco J; Molés JR; Boscá M; Cortés E
    PLoS One; 2015; 10(5):e0128156. PubMed ID: 26011514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.